Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
new york blog main
5
×
new york top stories
san francisco blog main
san francisco top stories
national top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
clinical trial
clinical trials
dna sequencing
fda
loxo oncology
study
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
What
cancer
5
×
new
5
×
bio
cut
genetic
immunotherapy
medicine
medicines
second
time
aim
allogene
approved
bets
boost
centers
change
comes
community
companies
crispr
date
deal
deeper
depression
diagnostics
diversity
dna
docs
drug
effective
enticed
event
evidence
fda
fingerprint
flatiron
going
guesswork
guide
Language
Current search:
cancer
×
new
×
" new york blog main "
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
